<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Li, Wei</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Th17-Prone CD146+CCR5+ T-Cell Population Is an Early Marker of Intestinal GVHD</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">8-8</style></pages><abstract><style  face="normal" font="default" size="100%">Allogeneic hematopoietic stem-cell transplantation is a promising treatment approach in patients who require hematopoietic stem cell transplantation. A significant drawback is the occurrence of acute graft-vs-host disease, which occurs when newly transplanted donor lymphocytes attack the transplant recipient's body. The discovery of the Th17-prone CD146+CCR5+ T-cell population may be an early biomarker for intestinal graft-vs-host disease leading to more specific preventions strategies.</style></abstract><number><style face="normal" font="default" size="100%">55</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>